Government of Taiwan   Report issue

Government Phase 1 Phase 2 Phase 3 Phase 4
Founded: Nanking Taiwan (1912)

Organization Overview

First Clinical Trial
1994
NCT00201344
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

1.Tri-service General hospital, Songshan branch, Taipei, Taiwan | Beitou Armed Forces Hospital, Taipei, Taiwan | Centers for Disease Control, Taiwan | Department of Anesthesiology, Tri-Service General Hospital | Department of Health, Executive Yuan, R.O.C. (Taiwan) | Department of Health, Executive Yuan, Taiwan | Department of Health, Taiwan | Department of Opthalmology/ Tri-Service General Hospital | Department of Physical Medicine and Rehabilitation, Tri-Service General Hospital | Department of Physical Medicine and Rehabilitation, Tri-Service General Hospital, National Defense Medical Center | Department of Physical Medicine and Rehabilitation, Tri-Service General Hospital, National Defense Medical Center, | Department of Psychiatry, Beitou Armed Forces Hospital, Taipei, Taiwan | Department of rehabiliation,TSGH, Taipei, Taiwan | Development Center for Biotechnology, Taiwan | Division of Hematology/Oncology, Tri-Service General Hospital | Division of Occupational Therapy,Taipei Hospital, Ministry of Health and Welfare | Institute of Nuclear Energy Research, Taiwan | Institute of Occupational Safety and Health, Taiwan | Lin, Hsi-Hsun, M.D. | Ministry of Health and Welfare, Taiwan | Ministry of Science and Technology | Ministry of Science and Technology, R.O.C. | Ministry of Science and Technology, Taipei, Taiwan | Ministry of Science and Technology, Taiwan | Ministry of Science and Technology, Taiwan, ROC | National Council on Science Development | National Defense Medical Center, Taiwan | National Health Command Center, Centers for disease control, Department of Health, Taiwan, R.O.C | National Health Research Institutes, Taiwan | National Health Research of Institutes, Taiwan Cooperative Oncology Group | National Insitute of Cancer Research | National Institute of Cancer Research, National Health Research Institutes, Taiwan | National Institute of Cancer Research, National Health Research Institution, Taiwan | National Science Council, Taiwan | Public Health Bureau,Taoyan County Governmnet, Taiwan | Taipei City Hospital, Ren-Ai Branch | Taipei Hospital, Department of Health, Taiwan, R.O.C. | Taipei Municipal Hospital, Ren-Ai Branch | Taipei Municipal Wanfang Hospital | Taipei Municipal Wang-Feng Hospital | Taiwan Military | Taiwan Ministry of Science and Technology | Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan | Tri-Service General Hospital | TriService General Hospital | Tri-Service General Hospital National Defense Medical Center | Tri-Service General Hospital, National Defense Medical Center | Tri-Service General Hospital National Defense Medical Center, Taiwan | Tri-Service General Hospital, Taipei, Taiwan | Tri-Service General Hospital, Taiwan ROC

Active Ingredients

Drugs in Phase 4 Trials (74)

agomelatine (Valdoxan) (1 trial)

albumin (Human) (Plasbumin) (1 trial)

aliskiren (tekturna) (1 trial)

amisulpride (BARHEMSYS) (2 trials)

amoxicillin (1 trial)

apixaban (eliquis) (1 trial)

aripiprazole (abilify) (6 trials)

benzbromarone (1 trial)

bismuth (2 trials)

brimonidine (alphagan) (1 trial)

bupropion (wellbutrin) (1 trial)

carteolol (cartrol) (1 trial)

carvedilol (coreg) (1 trial)

cholesterol (2 trials)

cilostazol (pletal) (4 trials)

citalopram (celexa) (2 trials)

clarithromycin (biaxin) (5 trials)

clozapine (clozaril) (1 trial)

dabigatran (pradaxa) (1 trial)

dextromethorphan (delsym) (5 trials)

entecavir (baraclude) (3 trials)

esomeprazole (nexium) (2 trials)

febuxostat (uloric) (1 trial)

fluoxetine (prozac) (2 trials)

fluvoxamine (luvox) (1 trial)

garlic (1 trial)

gemfibrozil (lopid) (1 trial)

ginseng (1 trial)

hydroxychloroquine (plaquenil) (1 trial)

inactivated influenza vaccine (2 trials)

interferon alpha-2b (Intron-A) (11 trials)

isoniazid (nydrazid) (2 trials)

isosorbide (isordil) (1 trial)

lamotrigine (lamictal) (1 trial)

latanoprost (xalatan) (1 trial)

ledipasvir (Harvoni) (1 trial)

levobupivacaine (chirocaine) (1 trial)

levofloxacin (levaquin) (2 trials)

levothyroxine (Synthroid) (1 trial)

lovastatin (mevacor) (1 trial)

methylphenidate (ritalin) (2 trials)

metronidazole (flagyl) (5 trials)

nadolol (corgard) (3 trials)

nicotine (nicorette) (1 trial)

nivolumab (opdivo) (3 trials)

olanzapine (zyprexa) (5 trials)

omeprazole (prilosec) (4 trials)

onabotulinumtoxinA (Botox) (1 trial)

pantoprazole (protonix) (3 trials)

paroxetine (paxil) (1 trial)

platelet-rich plasma (8 trials)

pneumococcal 7-valent conjugate vaccine (Prevnar) (1 trial)

pregabalin (lyrica) (1 trial)

procaine benzylpenicillin (novocaine) (6 trials)

propofol (diprivan) (3 trials)

quetiapine (seroquel) (2 trials)

rabeprazole (pariet) (3 trials)

raltegravir (isentress) (1 trial)

remifentanil (ultiva) (2 trials)

ribavirin (virazole) (8 trials)

rimabotulinumtoxinB (Myobloc) (2 trials)

risperidone (risperdal) (3 trials)

rivaroxaban (xarelto) (1 trial)

sevoflurane (ultane) (3 trials)

shen pu yang gan wan (1 trial)

sibelium (1 trial)

sodium chloride (2 trials)

sofosbuvir (sovaldi) (1 trial)

somatostatin (1 trial)

terlipressin (Terlivaz) (2 trials)

timolol (blocadren) (2 trials)

valproic acid (depakene) (2 trials)

valsartan (diovan) (1 trial)

venlafaxine (effexor) (1 trial)

Drugs in Phase 3 Trials (34)

allogeneic natural killer cells (3 trials)

amphotericin b (fungizone) (1 trial)

astragalus membranaceus (3 trials)

atorvastatin (lipitor) (3 trials)

betamethasone (celestone) (1 trial)

celecoxib (celebrex) (3 trials)

cisplatin (platinol) (7 trials)

cyclophosphamide (cytoxan) (3 trials)

diclofenac (voltaren) (1 trial)

epirubicin (ellence) (3 trials)

ethambutol (myambutol) (1 trial)

fluorouracil (efudex) (10 trials)

gefitinib (iressa) (1 trial)

huexc030 (1 trial)

icosapent ethyl (vascepa) (9 trials)

l-epigallocatechin (3 trials)

leucovorin (16 trials)

memantine (namenda) (4 trials)

minocycline (minocin) (1 trial)

mitomycin (mutamycin) (2 trials)

nalbuphine (nubain) (3 trials)

niacin (1 trial)

pemetrexed (alimta) (1 trial)

pentoxifylline (trental) (2 trials)

pitavastatin (livalo) (1 trial)

prednisone (meticorten) (2 trials)

pyrazinamide (Aldinamide) (1 trial)

retinoic acid (1 trial)

rifampin (1 trial)

rifapentine (priftin) (1 trial)

tamoxifen (nolvadex) (2 trials)

thalidomide (Thalomid) (4 trials)

thrombin (bovine) (Thrombostat) (1 trial)

urea (1 trial)

Drugs in Phase 2 Trials (76)

13c-pyruvate (1 trial)

acetylcysteine (mucomyst) (1 trial)

afatinib (gilotrif) (1 trial)

atezolizumab (Tecentriq) (1 trial)

axitinib (inlyta) (1 trial)

bevacizumab (avastin) (2 trials)

bi 754091 (1 trial)

blex 404 (1 trial)

cabozantinib (cometriq) (1 trial)

capecitabine (xeloda) (1 trial)

carboplatin (paraplatin) (1 trial)

cea-loaded dendritic cells (1 trial)

ceftolozane (Zerbaxa) (1 trial)

ceritinib (zykadia) (1 trial)

cetuximab (erbitux) (3 trials)

daaoi (1 trial)

daaoi-1 (1 trial)

daaoi-2 (1 trial)

dcb-ad1 (1 trial)

Dihydrotetrabenazine (3 trials)

Dimethylcurcumin (1 trial)

Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine (Kinrix) (1 trial)

docetaxel (taxotere) (2 trials)

donepezil (aricept) (1 trial)

doxorubicin (Doxil) (1 trial)

d-serine (1 trial)

durvalumab (imfinzi) (1 trial)

etoposide (vepesid) (1 trial)

everolimus (zortress) (1 trial)

fludeoxyglucose f-18 (1 trial)

ga68-dolacga (2 trials)

gemcitabine (gemzar) (15 trials)

gimeracil (7 trials)

glucose (1 trial)

hyaluronic acid (3 trials)

i-123-adam (1 trial)

imatinib (gleevec) (1 trial)

indigo (2 trials)

indirubin sulfate (1 trial)

ipilimumab (yervoy) (1 trial)

irinotecan (Camptosar) (5 trials)

lamivudine (epivir) (1 trial)

lanreotide (somatuline depot) (1 trial)

lansoprazole (prevacid) (1 trial)

lenalidomide (revlimid) (1 trial)

lenvatinib (lenvima) (1 trial)

lesogaberan (1 trial)

letrozole (femara) (1 trial)

Luminespib (1 trial)

methylprednisolone (medrol) (1 trial)

naltrexone (revia) (1 trial)

nemonoxacin (2 trials)

oteracil (7 trials)

oxaliplatin (eloxatin) (12 trials)

paclitaxel (taxol) (6 trials)

pembrolizumab (keytruda) (1 trial)

ph3 (1 trial)

rhodiola (1 trial)

rituximab (rituxan) (3 trials)

ruxolitinib (jakafi) (1 trial)

s-1 (4 trials)

sarcosine (4 trials)

sertraline (zoloft) (2 trials)

sodium benzoate (1 trial)

sorafenib (nexavar) (2 trials)

ss-1 (1 trial)

sta-1 (1 trial)

tacrolimus (prograf) (1 trial)

tegafur (9 trials)

temozolomide (temodar) (1 trial)

tlc 388 (1 trial)

tumor-pulsed dendritic cells (1 trial)

twb-103 (1 trial)

txb-103 (1 trial)

uracil (1 trial)

vincristine (oncovin) (1 trial)

Drugs in Phase 1 Trials (24)

186re-bmeda (1 trial)

2-carba-cyclic phosphatidic acid (1 trial)

antroquinonol (1 trial)

asiaticoside a (1 trial)

bmec-1217b (1 trial)

budesonide (rhinocort) (2 trials)

dbpr110 (1 trial)

dbpr112 (1 trial)

dcb-dm101 (1 trial)

ev71 vaccine (1 trial)

granisetron (kytril) (1 trial)

hlx10 (1 trial)

hlx55 (1 trial)

hydrogen (1 trial)

long dan xie gan tang (1 trial)

morphine (1 trial)

ob318 (1 trial)

procaterol (2 trials)

prusogliptin (2 trials)

salvigenin (1 trial)

trastuzumab (herceptin) (1 trial)

tt-00434 (1 trial)

valaciclovir (Valtrex) (1 trial)

welgenaleucel (1 trial)

Drugs in Other Trials (45)

acarbose (precose) (1 trial)

allogeneic bone marrow (1 trial)

arginine (1 trial)

autologous microbiome (1 trial)

brown seaweed (1 trial)

celery (1 trial)

chlorella (1 trial)

chlorhexidine (hibitane) (1 trial)

citric acid (1 trial)

clonazepam (klonopin) (1 trial)

cobalamin (1 trial)

dextrose (2 trials)

escitalopram (lexapro) (1 trial)

etanercept (enbrel) (1 trial)

glucose monohydrate (3 trials)

hepatitis b vaccine (recombinant) (Recombivax) (3 trials)

indirubin (1 trial)

kremezin (1 trial)

lactobacillus casei (1 trial)

lactobacillus fermentum (1 trial)

levetiracetam (keppra) (2 trials)

lidocaine (xylocaine) (4 trials)

magnesium citrate (1 trial)

nitroglycerin (transderm-nitro) (1 trial)

olive (1 trial)

omega-3 fatty acids (Omacor) (1 trial)

onion (1 trial)

perampanel (fycompa) (1 trial)

piperacillin (pipracil) (1 trial)

prilocaine (citanest) (1 trial)

qingre liangkou ningxin fang (1 trial)

rosuvastatin (crestor) (1 trial)

shea nut oil extract (1 trial)

sitagliptin (januvia) (3 trials)

snp-612 (1 trial)

soybean (2 trials)

spinach (1 trial)

spirulina (1 trial)

sucralose (1 trial)

tazobactam (Zosyn) (1 trial)

tolterodine (detrol) (1 trial)

topiramate (topamax) (1 trial)

trazodone (desyrel) (1 trial)

triamcinolone (kenalog) (2 trials)

urea-13c (PyloPlus) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 2)

Acute Disease (Phase 2)

Adenocarcinoma (Phase 2)

Altitude Sickness (Phase 2)

Alzheimer Disease (Phase 2)

Amphetamine-Related Disorders (Phase 3)

Aneurysm (Phase 2)

Ankle Injuries (Phase 4)

Asthma (Phase 1)

Atrial Fibrillation (Phase 4)

Attention Deficit Disorder with Hyperactivity (Phase 4)

Behavior, Addictive (Phase 3)

Biliary Tract Diseases (Phase 2)

Biliary Tract Neoplasms (Phase 2)

Bipolar Disorder (Phase 4)

Blindness (Phase 3)

Breast Neoplasms (Phase 2)

Bunion (Phase 4)

Carcinoma (Phase 3)

Carcinoma, Ductal (Phase 3)

Carcinoma, Ductal, Breast (Phase 3)

Carcinoma, Hepatocellular (Phase 4)

Carcinoma in Situ (Phase 3)

Carcinoma, Intraductal, Noninfiltrating (Phase 3)

Carcinoma, Neuroendocrine (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Squamous Cell (Phase 3)

Cardiovascular Diseases (Phase 4)

Cerebral Infarction (Phase 4)

Cholangiocarcinoma (Phase 2)

Chronic Pain (Phase 4)

Colonic Diseases (Phase 2)

Colorectal Neoplasms (Phase 2)

Communicable Diseases (Phase 4)

Coronary Aneurysm (Phase 2)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Coronavirus Infections (Phase 4)

Deafness (Phase 2)

Dementia (Phase 2)

Dengue (Phase 2)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Major (Phase 4)

Dermatitis (Phase 2)

Dermatitis, Atopic (Phase 2)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Diabetic Foot (Phase 2)

Diabetic Nephropathies (Phase 2)

Disease (Phase 4)

Drug-Related Side Effects and Adverse Reactions (Phase 4)

Duodenal Ulcer (Phase 4)

Dyskinesia, Drug-Induced (Phase 4)

Dyskinesias (Phase 4)

Dystonia (Phase 4)

Eczema (Phase 2)

Enterovirus Infections (Phase 1)

Environmental Illness (Phase 2)

Esophageal and Gastric Varices (Phase 4)

Fatigue (Phase 3)

Fibromyalgia (Phase 4)

Fibrosis (Phase 4)

Focal Infection (Phase 2)

Foot Ulcer (Phase 2)

Gastritis (Phase 2)

Gastroesophageal Reflux (Phase 2)

Gastrointestinal Hemorrhage (Phase 2)

Gastrointestinal Stromal Tumors (Phase 2)

Glaucoma (Phase 4)

Glioblastoma (Phase 2)

Glioma (Phase 2)

Glomerulonephritis (Phase 3)

Goiter (Phase 4)

Hallux Valgus (Phase 4)

Head and Neck Neoplasms (Phase 2)

Hearing Loss (Phase 2)

Hearing Loss, Noise-Induced (Phase 2)

Heart Failure (Phase 4)

Helicobacter Infections (Phase 4)

Hemorrhage (Phase 4)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 4)

Hepatitis, Chronic (Phase 4)

Hepatitis D (Phase 4)

Hepatitis D, Chronic (Phase 4)

Herpesviridae Infections (Phase 2)

HIV Infections (Phase 4)

Hyperalgesia (Phase 4)

Hypercholesterolemia (Phase 3)

Hyperkinesis (Phase 4)

Hyperlipidemias (Phase 3)

Hyperlipoproteinemias (Phase 3)

Hypertension (Phase 4)

Hyperuricemia (Phase 4)

Hypoalbuminemia (Phase 4)

Immune System Diseases (Phase 4)

Infections (Phase 4)

Inflammation (Phase 4)

Influenza, Human (Phase 4)

Insulin Resistance (Phase 4)

Ischemia (Phase 4)

Kidney Diseases (Phase 2)

Klatskin Tumor (Phase 2)

Leishmaniasis (Phase 3)

Leishmaniasis, Visceral (Phase 3)

Liver Cirrhosis (Phase 4)

Liver Neoplasms (Phase 3)

Lung Diseases, Obstructive (Phase 1)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 2)

Lymphoma, B-Cell (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 2)

Lymphoma, Non-Hodgkin (Phase 2)

Mental Disorders (Phase 2)

Metabolic Syndrome (Phase 4)

Mouth Neoplasms (Phase 3)

Mucocutaneous Lymph Node Syndrome (Phase 2)

Myocardial Ischemia (Phase 4)

Nasopharyngeal Carcinoma (Phase 3)

Neoplasm Metastasis (Phase 2)

Neoplasms (Phase 2)

Nephrosis (Phase 3)

Nephrotic Syndrome (Phase 3)

Nerve Degeneration (Phase 2)

Neurodegenerative Diseases (Phase 2)

Obesity (Phase 4)

Ocular Hypertension (Phase 4)

Osteoarthritis (Phase 2)

Osteoarthritis, Knee (Phase 1)

Pain, Postoperative (Phase 4)

Pancreatic Neoplasms (Phase 2)

Parkinson Disease (Phase 2)

Parkinsonian Disorders (Phase 4)

Peptic Ulcer (Phase 4)

Peptic Ulcer Hemorrhage (Phase 4)

Peripheral Arterial Disease (Phase 4)

Peripheral Vascular Diseases (Phase 4)

Pneumococcal Infections (Phase 4)

Pneumonia (Phase 2)

Pneumothorax (Phase 3)

Prostatic Neoplasms (Phase 2)

Psoriasis (Phase 2)

Psychotic Disorders (Phase 4)

Pulmonary Disease, Chronic Obstructive (Phase 1)

Rectal Neoplasms (Phase 2)

Recurrence (Phase 4)

Sarcoma (Phase 2)

Schizophrenia (Phase 4)

Severe Acute Respiratory Syndrome (Phase 4)

Sjogren's Syndrome (Phase 2)

Somatoform Disorders (Phase 4)

Sprains and Strains (Phase 4)

Stomach Neoplasms (Phase 2)

Stroke (Phase 4)

Syndrome (Phase 4)

Tardive Dyskinesia (Phase 4)

Tobacco Use Disorder (Phase 4)

Triple Negative Breast Neoplasms (Phase 2)

Tuberculosis (Phase 4)

Tuberculosis, Pulmonary (Phase 3)

Ulcer (Phase 4)

Uterine Cervical Neoplasms (Phase 2)

Varicose Veins (Phase 3)

Ventricular Dysfunction, Left (Phase 4)

Virus Diseases (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 288
  • # of Trial APIs: 253